Morgan Stanley Knock-Out BMRN/ DE000MB5UQM0 /
21.05.2024 09:57:30 | Diff.-0,05 | Geld14:26:49 | Brief14:26:49 | Basiswert | Basispreis | Fälligkeit | Optionsart |
---|---|---|---|---|---|---|---|
2,98EUR | -1,65% | 2,99 Geld Vol: 750 |
3,04 Brief Vol: 750 |
BioMarin Pharmaceuti... | 109,5817 - | 31.12.2078 | Put |
Newsfile Corp
14:30
Kenorland Arranges Strategic Investment by Centerra Gold Through C$9.86M Non-Brokered Private Placem...
Newsfile Corp
14:30
PurMinds Chief Scientific Officer to Speak at the 4th Annual Psychedelic Therapeutics and Drug Devel...
GlobeNewswire
14:30
Navitas Drives High-power, High-reliability, Next-gen Power Semis for AI, EV, Industrial, Solar, and...
GlobeNewswire
14:30
La Rosa Appoints Corporate Finance Executive Lourdes Felix to its Board of Directors
GlobeNewswire
14:30
PodcastOne’s (Nasdaq: PODC) LADYGANG Podcast Presents the “You Never Forget Your First” Tour Present...
GlobeNewswire
14:30
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for G...
GlobeNewswire
14:30
ValueCoach AI Tool Announced by ValueSelling Associates at Gartner CSO & Sales Leader Conference 202...
GlobeNewswire
14:30
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent...
GlobeNewswire
14:30
Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™...
GlobeNewswire
14:30
Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At Am...
Newsfile Corp
14:15
Vinexposium Sets the Stage for Global Expansion with Upcoming Vinexpo America 2024 in New York
GlobeNewswire
14:15
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite